FDA DEVICE FACTS
Neonatal Phototherapy System
Avalon Biomedical (Shenzhen) Limited
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Neonatal Phototherapy Sys tem, Model: KANGALITE is intended for the treatm ent of unconjugated hyperbilirubinem ia in the population of neonates: gestational age ≥38 weeks and
weight within 2500-4500 grams. It can be used in the clinical setting or in the hom e environm ent. It should be used for neonates whom phototherapy has been prescribed.
Contraindication
The Neonatal Phototherapy System , Model: KANG ALITE sho uld NOT be used in cases of : (a) Congenital porphyri a or a fam ily history of porphyria (b) Concom itant use of drugs or agents that are photosensitizers A use that does not take into account these contraindications may lead to an ineffective treatment or to potential ris ks to the patient’s health.
The Bili-Tx is intended to treat hyperbilirubinem ia through phototherapy in a hom e or hospital/institutional environm ent.
Different See comment 1
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。